Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry

Cited by (930)

Items 901–930 of 930

1. Baseline vs. on-treatment heart failure with preserved ejection fraction (HFpEF) in a real world cardio-oncology clinic: observational analysis of cancer therapy-related cardiovascular toxicity incidence and cancer treatment implications
   Berlinde A. von Kemp, Xavier Galloo, Bram Roosens, Bart Neyns, Rik Schots, Mark De Ridder, Bernard Cosyns · 2026 · Frontiers in Cardiovascular Medicine
2. Cardio‐Oncologic Considerations in Heart Failure With Mildly Reduced Ejection Fraction: Prevalence and Prognostic Impact of Malignancies
   Tobias Schupp, Michelle Goertz, Jonas Dudda, Mohammad Abumayyaleh, Kathrin Weidner, Alexander Schmitt, Felix Lau, Marielen Reinhardt, Noah Abel, Jonas Rusnak et al. · 2026 · Journal of the American Heart Association
3. Multi-Chamber Reverse Remodeling and Hemodynamic Force Realignment After SGLT2 Inhibitor Initiation in Real-World Heart Failure
   Silvia Prosperi, Sara Monosilio, Andrea D’Amato, Danilo Angotti, Domenico Filomena, Lucrezia Netti, Giovanni Tonti, Gianni Pedrizzetti, Sara Cimino, Roberto Badagliacca et al. · 2026 · Journal of Cardiovascular Development and Disease
4. Efficacy and safety of vericiguat in patients with heart failure with reduced ejection fraction and asymptomatic hypotension: insights from a multicenter observational cohort study
   Jiangyue Tian, Shufang Chen, Guihua Zhang, Xiaoning Jia, Luyao An, Xuyang Duan, Yarui Zhao, Changjiang Wei, Haitao Zhang, Xiaowei Li et al. · 2026 · BMC Cardiovascular Disorders
5. Left and right ventricular echocardiographic patterns in cardiogenic pulmonary edema: An exploratory retrospective study
   Dan Cristian Popescu, Mara Diaconu, Diana Ţînţ, Alexandru Cristian Nechita · 2026 · World Journal of Cardiology
6. Proteomic markers enhance mortality prediction in heart failure
   Pascal B. Meyre, Yanran Li, Guilherme L. da Rocha, Elad Shemesh, Michael Chong, Ambuj Roy, Kamilu Musa Karaye, Stefan Störk, Lisa Mielniczuk, Sanjib Kumar Sharma et al. · 2026 · European Heart Journal
7. Quantitative CMR-derived pulmonary circulation imaging biomarkers in recent-onset dilated cardiomyopathy associated with pulmonary hemodynamics and clinical improvement
   Lukáš Opatřil, Mary Luz Mojica‐Pisciotti, Roman Panovský, Jan Máchal, Tomáš Holeček, Věra Feitová, Július Godava, Hana Poloczková, Vladimír Kincl, Jan Krejčí · 2026 · BMC Medical Imaging
8. Differentiating HFmr/rEF from HFpEF using standard 12-lead ECG measurements: an interpretable machine learning study
   Chenxu Zhao, Po Jie Chan, Scott Dougherty, Yiting Fan, Alex Pui‐Wai Lee · 2026 · Open Heart
9. Imaging-based Demonstration of Reverse Left Heart Remodeling after Sodium–Glucose Co-transporter 2 Inhibitors in Heart Failure: A Systematic Review and Meta-analysis
   Federico Giannino, Luigi Colarusso, Matteo Mancuso, Maurizio Cusmà Piccione, Gianluca Di Bella, Antonio Micari, Concetta Zito · 2026 · Journal of Cardiovascular Echography
10. Differences between men and women in guideline-directed medical therapy implementation, tolerability, and outcomes in heart failure with reduced ejection fraction
    Mariëlle I Wilde, J J N Krabbe, L. J. Bouhuijzen, Gerardus P. J. van Hout, Michelle M de Leau, K W Wu, Eugène A. van Beek, Tim Hesselink, Lennaert Kleijn, Maurice J Kurvers et al. · 2026 · European Heart Journal - Quality of Care and Clinical Outcomes
11. Left Atrial Reservoir Strain Combined With Left Ventricular Longitudinal Strain Improves Discrimination of HFpEF in Patients With Hypertension
    Jianan Zhang, Yue Lv, Xiuqun Cao, Lin Liu, Zhe Xu, Qingyue Han, Wenjia Wang, Yang Song, Peishi Yan, Xiaolin Mu · 2026 · Journal of Clinical Hypertension
12. Mineralocorticoid receptor overactivation in heart failure with preserved ejection fraction
    Masatake Kobayashi, Bertram Pitt, Faiez M. Zannad · 2026 · European Heart Journal
13. Patterns of spironolactone management following hyperkalemia among hospitalized patients with heart failure and reduced ejection fraction: a retrospective single-center study
    Abdullah Alshammari, Foud O. Bahamdain, Asma M. Alshahrani, Geetha Kandasamy, Ageeli Rabea Mussa Rabea, Wid Alyamani, Anas Idris, Yara Kamfar, Maher Almalki, Saleh Alghamdi et al. · 2026 · Frontiers in Medicine
14. Clinical and Metabolic Predictors of Ventricular Arrhythmias in Heart Failure with Preserved Ejection Fraction: A Nationwide Inpatient Study —Predictors of Ventricular Arrhythmias in Heart Failure with Preserved Ejection Fraction
    Parjanya Bhatt, Priyadarshini Dixit, Isra Algburi, Riaz Mahmood, Ugochukwu Onyibo Egolum, Geetha Krishnamoorthy · 2026 · World Journal of Cardiovascular Diseases
15. Discharge use of mineralocorticoid receptor antagonists and long-term outcomes in HFpEF
    Takashi Morinaga, Masahiro Natsuaki, Akihiro Isotani, Kenji Kanenawa, Ko Yamamoto, Masato Fukunaga, Ayumu Yajima, Makoto Hyodo, Shinichi Shirai, Kenji Andò et al. · 2026 · Journal of Cardiology
16. Different diuretic regimes and long-term outcomes in heart failure with mildly reduced ejection fraction
    Alexander Schmitt, Michael Behnes, Marielen Reinhardt, Noah Abel, Felix Lau, Kathrin Weidner, Mohammad Abumayyaleh, Michael Hagmann, İbrahim Akın, Tobias Schupp · 2026 · Current Medical Research and Opinion
17. The treatment of selected traditional Chinese medicine prescriptions and their metabolites for heart failure with preserved ejection fraction from basic science discovery to the clinic
    Yanhong Zhang, Wanqing Wu, Xi Zhai, Jingkai Zhang, Weidong Wang, Xinyuan Huang, Lan Wu · 2026 · Frontiers in Pharmacology
18. Development and validation of a nurse-led mHealth and module-based educational intervention for heart failure patients
    Nipin Kalal, Suresh K. Sharma, Ashok Kumar, Surender Deora · 2026 · BMC Digital Health
19. Patient‐Reported Quality of Life‐Based Machine Learning Model Predicting Sudden Cardiac Death in Heart Failure With Preserved Ejection Fraction: Kansas City Cardiomyopathy Questionnaire‐Based Sudden Cardiac Death Score
    Xiao Liu, Zenghui Zhang, Mingyue Cui, Chunjie Shu, Weiliang Yu, Hong Pan, Ayiguli Abudukeremu, Ke Zhao, Minglong Zheng, Zhengyu Cao et al. · 2026 · Medicine Advances
20. Diretriz Brasileira de Insuficiência Cardíaca – 2026
    Marcus Vinı́cius Simões, Lídia Zytynski Moura, Sílvia Marinho Martins, Ricardo Mourilhe‐Rocha, Luiz Cláudio Danzmann, José Albuquerque de Figueiredo Neto, Fabiana G. Marcondes‐Braga, Múcio Tavares de Oliveira, Denílson Campos de Albuquerque, Aguinaldo Figueiredo Freitas et al. · 2026 · Arquivos Brasileiros de Cardiologia
21. Pronóstico a 1año en pacientes con insuficiencia cardíaca y enfermedad renal crónica: diferencias en relación con el tipo de insuficiencia cardíaca y la gravedad de la insuficiencia renal
    María Anguita Gámez, Rafael Gonzalez-Manzanares, Juan L. Bonilla‐Palomas, Alberto Esteban‐Fernández, Alejandro Recio Mayoral, Javier Muñiz, Martin Ruiz-Ortiz, Manuel Crespín-Crespín, Manuel Anguita-Sánchez, Dolores Mesa-Rubio · 2026 · Medicina Clínica
22. Insuficiencia cardíaca crónica en Argentina. OFFICE IC AR, un registro conjunto de la Sociedad Argentina de Cardiología y de la Federación Argentina de Cardiología
    Jorge Mario Thierer, Eduardo Roque Perna, Javier Marino, María Lorena Coronel, José Luis Barisani, Daniela García Brasca, Paula Pérez Terns, Juan Pablo Cimbaro Canella, Stella M. Pereiro · 2022 · Revista Argentina de Cardiología
23. Does etiology matter only in HFmrEF? Data from the HEart failuRe ObsErvational Study (HEROES)
    Michał Tarnowski, Karolina Molenda, Robert Morawiec, Agata Anna Galas, Przemysław Leszek, Paweł Maeser, Agata Tymińska, Adrian Stefański, Jarosław Dróżdż, Iwona Gorczyca−Michta · 2026 · Archives of Medical Science
24. Temporal trajectories of real-life hospital laboratory data measured during usual care predict clinical outcome in patients with HFpEF in both sexes
    ezgi hatip ünlü, Thomas F. Kok, Mylène Barry - Loncq de Jong, Pieter F. van den Berg, Navin Suthahar, Robert M. A. van der Boon, Wouter C. Meijers, Rudolf A. de Boer, Jasper Jan Brugts, Eric H. Boersma et al. · 2026 · International Journal of Cardiology Cardiovascular Risk and Prevention
25. Insuficiencia cardíaca: manejo perioperatorio
    A. Jendoubi, T. Damy, N. Mongardon · 2026 · EMC - Anestesia-Reanimación
26. Systemic Inflammation and Adverse Heart Failure Outcomes
    Alexander T. Sandhu, Adam Furst, Anubodh Sunny Varshney, Karim Sallam, Stephanie Hsiao, Anthony Gromovsky, Kat Wolf Khachatourian, Natasha Din, Jeffrey Rolf Skaar, Ivy Q. Tonnu-Mihara · 2026 · JACC Advances
27. Depression and Heart Failure With Preserved Ejection Fraction: An Inflammatory Perspective
    Hongfan Chen, Nan Zhang, Yufan Feng, Mengxing Tao, Chi Geng · 2026 · Depression and Anxiety
28. Rastreo poblacional con lipoproteína(a) en prevención primaria cardiovascular: una estrategia costoefectiva y potencialmente costoahorradora en determinados sistemas de salud
    Delfina Cecilia Ghezzi Prota · 2026 · Evidencia actualizacion en la práctica ambulatoria
29. Sex differences in clinical phenotypes and prognostic associations in acute heart failure
    Georgios Aletras, Maria Bachlitzanaki, Stylianos Fiflis, Eirini Bachlitzanaki, Eleni Eleftheriadou, Yannis Pantazis, Emmanuel Foukarakis, Michalis Hamilos, Kostas Stylianou · 2026 · Frontiers in Cardiovascular Medicine
30. Evaluation of risk factors for tricuspid regurgitation prior to cardiac pacemaker
    Shuangling Wang, Qiuzhe Guo, Li Li, Guochun Li, Ying Zhou, Yunfei Zhou, Guodong Niu, Yulong Guo · 2026 · Frontiers in Cardiovascular Medicine